In gliomas, hsa-mir-183 promotes cell proliferation, invasion, angiogenesis and radioresistance [41,42,43,44,45,46] and is overexpressed in NT-3 and NT-4 IDH-mutated gliomas. The gene discussed is NTF4; the disease is central nervous system cancer.